National Institutes of Health Acquired Immunodeficiency Syndrome Research Loan Repayment Program

The National Institutes of Health AIDS Research Loan Repayment Program (CFDA 93.936) is no longer in use and has not accepted new grant applications since 2006. The program's last grant award was disbursed on September 15, 2006, twenty years ago.

This program historically provided loan repayment support to recruit and retain trained researchers—physicians, registered nurses, and scientists—conducting AIDS research at the National Institutes of Health. Recent awards funded HIV prevention trials, AIDS clinical research, and related biomedical research across multiple NIH institutes and centers, including the National Institute of Mental Health, National Institute of Child Health and Human Development, and National Institute of Allergy and Infectious Diseases.

Over its active period, the program awarded 187 total grants distributing $117 million in federal dollars obligated. Funding was concentrated in the mid-2000s, with award volume declining from 42 grants in 2002 to 19 in 2005 before rising to 44 in the final year, 2006. Awards were predominantly Project Grants (99 percent of the portfolio), with one Cooperative Agreement and one Block Grant comprising the remainder. The National Institutes of Health was the sole funding agency across all 187 awards.

Recent awards included the HIV Prevention Trials Network (HPTN) Coordinating and Operations Center (awarded June 1, 2006, as a Cooperative Agreement obligating $56.1 million); Project Grant 1R01MH07439901A obligating $819 thousand for mental health research (August 15, 2006); and Project Grant 3P51RR00016445S obligating $845 thousand in research facility support (August 15, 2006). Most other awards in the 2005–2006 window fell in the $150 thousand to $600 thousand range, though several awards were substantially smaller.

The program accepts no new applications. Pursuit of this listing is not recommended; organizations seeking federal support for AIDS research should evaluate current active NIH funding mechanisms.